Cargando…
Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423876/ https://www.ncbi.nlm.nih.gov/pubmed/36060622 http://dx.doi.org/10.1016/j.ekir.2022.08.014 |
_version_ | 1784778112813236224 |
---|---|
author | Gueguen, Juliette Gatault, Philippe |
author_facet | Gueguen, Juliette Gatault, Philippe |
author_sort | Gueguen, Juliette |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9423876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94238762022-08-30 Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients Gueguen, Juliette Gatault, Philippe Kidney Int Rep Letter to the Editor Elsevier 2022-08-30 /pmc/articles/PMC9423876/ /pubmed/36060622 http://dx.doi.org/10.1016/j.ekir.2022.08.014 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Letter to the Editor Gueguen, Juliette Gatault, Philippe Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients |
title | Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients |
title_full | Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients |
title_fullStr | Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients |
title_full_unstemmed | Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients |
title_short | Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients |
title_sort | early administration of anti-sars-cov-2 monoclonal antibodies prevents severe covid-19 in kidney transplant patients |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423876/ https://www.ncbi.nlm.nih.gov/pubmed/36060622 http://dx.doi.org/10.1016/j.ekir.2022.08.014 |
work_keys_str_mv | AT gueguenjuliette earlyadministrationofantisarscov2monoclonalantibodiespreventsseverecovid19inkidneytransplantpatients AT gataultphilippe earlyadministrationofantisarscov2monoclonalantibodiespreventsseverecovid19inkidneytransplantpatients |